Search research articles
Contact Us
Filters
Showing results (961-970 of 994) with videos related to
Page
of 100
Sort By:
Antimicrobial Agents and Chemotherapy
|
August 6, 2014
Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval
Jessica Manning, Pattaraporn Vanachayangkul, Chanthap Lon, et al.
Antimicrobial Agents and Chemotherapy
|
May 28, 2015
Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance
Suwanna Chaorattanakawee, David L Saunders, Darapiseth Sea, et al.
Circulation. Heart Failure
|
February 12, 2017
Design and Rationale of a Randomized Trial of a Care Transition Strategy in Patients With Acute Heart Failure Discharged From the Emergency Department: GUIDED-HF (Get With the Guidelines in Emergency Department Patients With Heart Failure)
Gregory J Fermann, Phillip D Levy, Peter Pang, et al.
Ophthalmology
|
April 24, 2012
Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma
Michael D Onken, Lori A Worley, Devron H Char, et al.
Nature Plants
|
October 27, 2020
Genetic elucidation of interconnected antibiotic pathways mediating maize innate immunity
Yezhang Ding, Philipp R Weckwerth, Elly Poretsky, et al.
Bioorganic & Medicinal Chemistry
|
October 23, 2010
Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Na(v)1.8 sodium channel with efficacy in a model of neuropathic pain
Marc J C Scanio, Lei Shi, Irene Drizin, et al.
The Journal of Rheumatology
|
July 3, 2019
Chronic Joint Pain 3 Years after Chikungunya Virus Infection Largely Characterized by Relapsing-remitting Symptoms
Sarah R Tritsch, Liliana Encinales, Nelly Pacheco, et al.
Nature
|
December 20, 2013
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Frédéric Ariey, Benoit Witkowski, Chanaki Amaratunga, et al.
Circulation. Cardiovascular Quality and Outcomes
|
September 24, 2021
Improvement in Kansas City Cardiomyopathy Questionnaire Scores After a Self-Care Intervention in Patients With Acute Heart Failure Discharged From the Emergency Department
William B Stubblefield, Cathy A Jenkins, Dandan Liu, et al.
Journal of Emergency Nursing
|
July 14, 2010
The future of emergency medicine
Sandra M Schneider, Angela F Gardner, Larry D Weiss, et al.
Page
of 100
Search research articles
Search
Showing results (961-970 of 994) with videos related to
Sort By:
Page
of 100
Antimicrobial Agents and Chemotherapy
|
August 6, 2014
Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval
Jessica Manning, Pattaraporn Vanachayangkul, Chanthap Lon, et al.
Antimicrobial Agents and Chemotherapy
|
May 28, 2015
Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance
Suwanna Chaorattanakawee, David L Saunders, Darapiseth Sea, et al.
Circulation. Heart Failure
|
February 12, 2017
Design and Rationale of a Randomized Trial of a Care Transition Strategy in Patients With Acute Heart Failure Discharged From the Emergency Department: GUIDED-HF (Get With the Guidelines in Emergency Department Patients With Heart Failure)
Gregory J Fermann, Phillip D Levy, Peter Pang, et al.
Ophthalmology
|
April 24, 2012
Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma
Michael D Onken, Lori A Worley, Devron H Char, et al.
Nature Plants
|
October 27, 2020
Genetic elucidation of interconnected antibiotic pathways mediating maize innate immunity
Yezhang Ding, Philipp R Weckwerth, Elly Poretsky, et al.
Bioorganic & Medicinal Chemistry
|
October 23, 2010
Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Na(v)1.8 sodium channel with efficacy in a model of neuropathic pain
Marc J C Scanio, Lei Shi, Irene Drizin, et al.
The Journal of Rheumatology
|
July 3, 2019
Chronic Joint Pain 3 Years after Chikungunya Virus Infection Largely Characterized by Relapsing-remitting Symptoms
Sarah R Tritsch, Liliana Encinales, Nelly Pacheco, et al.
Nature
|
December 20, 2013
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Frédéric Ariey, Benoit Witkowski, Chanaki Amaratunga, et al.
Circulation. Cardiovascular Quality and Outcomes
|
September 24, 2021
Improvement in Kansas City Cardiomyopathy Questionnaire Scores After a Self-Care Intervention in Patients With Acute Heart Failure Discharged From the Emergency Department
William B Stubblefield, Cathy A Jenkins, Dandan Liu, et al.
Journal of Emergency Nursing
|
July 14, 2010
The future of emergency medicine
Sandra M Schneider, Angela F Gardner, Larry D Weiss, et al.
Page
of 100